Logo image of 1MRKX.MI

MERCK & CO. INC. (1MRKX.MI) Stock Price, Forecast & Analysis

Europe - BIT:1MRKX - US58933Y1055 - Common Stock

79.4 EUR
+4.7 (+6.29%)
Last: 11/12/2025, 7:00:00 PM

1MRKX.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap198.32B
Revenue(TTM)64.23B
Net Income(TTM)16.41B
Shares2.50B
Float2.50B
52 Week HighN/A
52 Week LowN/A
Yearly Dividend2.68
Dividend Yield3.78%
EPS(TTM)7.61
PE10.43
Fwd PE9.65
Earnings (Next)02-03 2026-02-03/amc
IPO1941-01-01
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


1MRKX.MI short term performance overview.The bars show the price performance of 1MRKX.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 5 10 15

1MRKX.MI long term performance overview.The bars show the price performance of 1MRKX.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1MRKX.MI is 79.4 EUR. In the past month the price increased by 14.41%.

MERCK & CO. INC. / 1MRKX Daily stock chart

1MRKX.MI Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
SAN.PA SANOFI 11.84 219.12B
SNW.DE SANOFI 11.89 220.16B
MRK.DE MERCK KGAA 13.95 51.63B
UCB.BR UCB SA 34.1 42.59B
1BAYN.MI BAYER AG-REG 5.81 28.59B
BAYN.DE BAYER AG-REG 5.89 28.45B
REC.MI RECORDATI INDUSTRIA CHIMICA 26.4 10.87B
IPN.PA IPSEN 12.66 10.90B
TUB.BR FINANCIERE DE TUBIZE 94.52 8.75B
VIRP.PA VIRBAC SA 20.56 2.99B
DMP.DE DERMAPHARM HOLDING SE 16.83 1.80B
MEDCL.PA MEDINCELL SA N/A 1.01B

About 1MRKX.MI

Company Profile

1MRKX logo image Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Company Info

MERCK & CO. INC.

126 East Lincoln Avenue, P.O. Box 2000

Rahway NEW JERSEY US

Employees: 75000

1MRKX Company Website

1MRKX Investor Relations

Phone: 19087404000

MERCK & CO. INC. / 1MRKX.MI FAQ

What does MERCK & CO. INC. do?

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.


What is the stock price of MERCK & CO. INC. today?

The current stock price of 1MRKX.MI is 79.4 EUR. The price increased by 6.29% in the last trading session.


Does 1MRKX stock pay dividends?

MERCK & CO. INC. (1MRKX.MI) has a dividend yield of 3.78%. The yearly dividend amount is currently 2.68.


What is the ChartMill technical and fundamental rating of 1MRKX stock?

1MRKX.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


Can you provide the sector and industry classification for MERCK & CO. INC.?

MERCK & CO. INC. (1MRKX.MI) operates in the Health Care sector and the Pharmaceuticals industry.


Can you provide the number of employees for MERCK & CO. INC.?

MERCK & CO. INC. (1MRKX.MI) currently has 75000 employees.


Can you provide the market cap for MERCK & CO. INC.?

MERCK & CO. INC. (1MRKX.MI) has a market capitalization of 198.32B EUR. This makes 1MRKX.MI a Large Cap stock.


1MRKX.MI Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to 1MRKX.MI.


Chartmill TA Rating
Chartmill Setup Rating

1MRKX.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to 1MRKX.MI. While 1MRKX.MI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1MRKX.MI Financial Highlights

Over the last trailing twelve months 1MRKX.MI reported a non-GAAP Earnings per Share(EPS) of 7.61. The EPS increased by 48.07% compared to the year before.


Industry RankSector Rank
PM (TTM) 25.79%
ROA 13.96%
ROE 33.49%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%70.7%
Sales Q2Q%3.72%
EPS 1Y (TTM)48.07%
Revenue 1Y (TTM)1.68%

1MRKX.MI Forecast & Estimates

33 analysts have analysed 1MRKX.MI and the average price target is 87.64 EUR. This implies a price increase of 10.38% is expected in the next year compared to the current price of 79.4.

For the next year, analysts expect an EPS growth of 18.21% and a revenue growth 1.08% for 1MRKX.MI


Analysts
Analysts75.76
Price Target87.64 (10.38%)
EPS Next Y18.21%
Revenue Next Year1.08%

1MRKX.MI Ownership

Ownership
Inst Owners80.53%
Ins Owners0.05%
Short Float %N/A
Short RatioN/A